Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis
- PMID: 19633429
- PMCID: PMC2903429
- DOI: 10.4161/cbt.8.17.9456
Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis
Figures

Comment on
-
Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents.Cancer Biol Ther. 2009 Sep;8(17):1651-8. doi: 10.4161/cbt.8.17.9283. Epub 2009 Sep 17. Cancer Biol Ther. 2009. PMID: 19597348
References
-
- Plas DR, Talapatra S, Edinger AL, Rathmell JC, Thompson CB. Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology. J Biol Chem. 2001;276:12041–8. - PubMed
-
- Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene. 2005;24:4165–73. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous